↓ Skip to main content

Dove Medical Press

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants

Overview of attention for article published in Biologics: Targets & Therapy, September 2008
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
72 Mendeley
Title
Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Published in
Biologics: Targets & Therapy, September 2008
DOI 10.2147/btt.s3104
Pubmed ID
Authors

Asunción Mejías, Octavio Ramilo

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
Egypt 1 1%
Unknown 69 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 19%
Student > Ph. D. Student 12 17%
Student > Bachelor 11 15%
Student > Master 11 15%
Other 6 8%
Other 8 11%
Unknown 10 14%
Readers by discipline Count As %
Medicine and Dentistry 26 36%
Agricultural and Biological Sciences 16 22%
Immunology and Microbiology 6 8%
Biochemistry, Genetics and Molecular Biology 5 7%
Engineering 2 3%
Other 4 6%
Unknown 13 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 April 2022.
All research outputs
#8,675,798
of 25,711,518 outputs
Outputs from Biologics: Targets & Therapy
#109
of 286 outputs
Outputs of similar age
#35,502
of 96,466 outputs
Outputs of similar age from Biologics: Targets & Therapy
#9
of 19 outputs
Altmetric has tracked 25,711,518 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 286 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one is in the 46th percentile – i.e., 46% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 96,466 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 5th percentile – i.e., 5% of its contemporaries scored the same or lower than it.